DK0880533T3 - Triazolderivater, der er egnede i terapi - Google Patents

Triazolderivater, der er egnede i terapi

Info

Publication number
DK0880533T3
DK0880533T3 DK97902288T DK97902288T DK0880533T3 DK 0880533 T3 DK0880533 T3 DK 0880533T3 DK 97902288 T DK97902288 T DK 97902288T DK 97902288 T DK97902288 T DK 97902288T DK 0880533 T3 DK0880533 T3 DK 0880533T3
Authority
DK
Denmark
Prior art keywords
therapy
triazole derivatives
derivatives useful
useful
triazole
Prior art date
Application number
DK97902288T
Other languages
English (en)
Inventor
Charles W Murtiashaw
Stuart Green
Peter T Stephenson
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Application granted granted Critical
Publication of DK0880533T3 publication Critical patent/DK0880533T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
    • C07F9/6518—Five-membered rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK97902288T 1996-02-02 1997-01-27 Triazolderivater, der er egnede i terapi DK0880533T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9602080.5A GB9602080D0 (en) 1996-02-02 1996-02-02 Pharmaceutical compounds
PCT/EP1997/000445 WO1997028169A1 (en) 1996-02-02 1997-01-27 Triazole derivatives useful in therapy

Publications (1)

Publication Number Publication Date
DK0880533T3 true DK0880533T3 (da) 2002-07-15

Family

ID=10787975

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97902288T DK0880533T3 (da) 1996-02-02 1997-01-27 Triazolderivater, der er egnede i terapi

Country Status (43)

Country Link
US (4) US6790957B2 (da)
EP (1) EP0880533B1 (da)
JP (1) JP2959846B2 (da)
KR (1) KR100283546B1 (da)
CN (1) CN1085213C (da)
AP (1) AP678A (da)
AT (1) ATE219089T1 (da)
AU (1) AU709781B2 (da)
BG (1) BG63946B1 (da)
BR (1) BR9707257A (da)
CA (1) CA2240777C (da)
CO (1) CO4761066A1 (da)
CZ (1) CZ291431B6 (da)
DE (1) DE69713284T2 (da)
DK (1) DK0880533T3 (da)
DZ (1) DZ2172A1 (da)
ES (1) ES2175336T3 (da)
GB (1) GB9602080D0 (da)
GT (1) GT199700016A (da)
HK (1) HK1018217A1 (da)
HN (1) HN1997000012A (da)
HR (1) HRP970063B1 (da)
HU (1) HU226133B1 (da)
ID (1) ID15858A (da)
IL (3) IL124865A (da)
IS (1) IS1995B (da)
MY (1) MY116849A (da)
NO (1) NO323771B1 (da)
NZ (1) NZ330654A (da)
OA (1) OA10711A (da)
PL (1) PL187237B1 (da)
PT (1) PT880533E (da)
RS (1) RS49526B (da)
RU (1) RU2176244C2 (da)
SA (1) SA97170578B1 (da)
SI (1) SI0880533T1 (da)
SK (1) SK283136B6 (da)
TN (1) TNSN97023A1 (da)
TR (1) TR199801440T2 (da)
TW (1) TW434247B (da)
UA (1) UA46828C2 (da)
WO (1) WO1997028169A1 (da)
ZA (1) ZA97826B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
GB9713149D0 (en) 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
DE19751525C2 (de) 1997-11-20 2003-02-13 Bat Cigarettenfab Gmbh Verfahren und Vorrichtung zur Regelung der Ausgangsfeuchte von Tabak
US6265584B1 (en) 1998-05-22 2001-07-24 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
AU1915500A (en) 1998-11-20 2000-06-13 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6235728B1 (en) 1999-02-19 2001-05-22 Bristol-Myers Squibb Company Water-soluble prodrugs of azole compounds
KR20010050557A (ko) * 1999-09-29 2001-06-15 타이도 나오카타 아졸 유도체 또는 그의 염
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6448401B1 (en) * 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds
US7540402B2 (en) * 2001-06-29 2009-06-02 Kva, Inc. Method for controlling weld metal microstructure using localized controlled cooling of seam-welded joints
US7323572B2 (en) 2002-07-16 2008-01-29 Pfizer Inc Process for controlling the hydrate mix of a compound
EP1646284A4 (en) * 2003-07-18 2008-09-24 Rhode Island Education AZOL DERIVATIVES AND METHOD FOR THEIR PREPARATION
CN101132802A (zh) * 2004-03-24 2008-02-27 法斯根有限责任公司 通过药理学抑制amp-活化的蛋白激酶的神经保护的新方法
CN1303073C (zh) * 2005-05-31 2007-03-07 中国人民解放军第二军医大学 取代三唑酮苄胺三唑醇类抗真菌化合物及其制备方法
US7803949B2 (en) * 2005-12-20 2010-09-28 Eisai R&D Management Co., Ltd. Process for preparation of water-soluble azole prodrugs
PL1968990T3 (pl) 2005-12-27 2015-06-30 Otsuka Pharma Co Ltd Rozpuszczalny w wodzie związek benzoazepinowy i jego kompozycja farmaceutyczna
CN101389333A (zh) * 2006-02-22 2009-03-18 卫材R&D管理有限公司 稳定化药物组合物
WO2009129300A2 (en) * 2008-04-15 2009-10-22 Schering Corporation High density compositions containing posaconazole and formulations comprising the same
CN101575330B (zh) * 2008-05-05 2012-10-31 丽珠医药集团股份有限公司 伏立康唑广谱抗真菌药物化合物、其组合物及用途
WO2011064558A2 (en) 2009-11-30 2011-06-03 Cipla Limited Pharmaceutical composition
EP2723452A2 (en) 2011-06-22 2014-04-30 Vyome Biosciences Pvt Ltd Conjugate-based antifungal and antibacterial prodrugs
EP2561863A1 (en) 2011-08-22 2013-02-27 Farmaprojects, S.A.U. Pharmaceutical compositions comprising voriconazole
KR102061137B1 (ko) * 2012-01-20 2019-12-31 마이코비아 파마슈티컬즈, 인코포레이티드 금속효소 억제제 화합물
DK3677252T3 (da) * 2012-03-19 2023-10-02 Cidara Therapeutics Inc Doseringsregimer for echinocandin-klasse forbindelser
CN103864844B (zh) * 2012-12-09 2016-10-05 正大天晴药业集团股份有限公司 一种福司氟康唑的制备方法
CN103304600B (zh) * 2013-03-04 2018-05-25 陕西合成药业股份有限公司 一种伏立康唑磷酸酯三水合物及其制备方法和用途
CA2904670A1 (en) 2013-03-14 2014-09-13 Fresenius Kabi Usa, Llc Voriconazole formulations
RU2719579C2 (ru) * 2013-03-14 2020-04-21 Сидара Терапьютикс, Инк. Режимы дозирования для соединений класса эхинокандинов
US20160128944A1 (en) 2013-06-04 2016-05-12 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
CN103524560A (zh) * 2013-09-28 2014-01-22 陕西合成药业有限公司 伏立康磷酸酯钠水合物及其多晶型
CN104650140B (zh) * 2013-11-18 2017-11-10 正大天晴药业集团股份有限公司 一种高纯度福司氟康唑的制备方法
AU2015212312A1 (en) 2014-01-29 2016-08-18 Vyome Therapeutics Limited Treatments for resistant acne
CN104860992A (zh) * 2014-02-25 2015-08-26 陕西合成药业股份有限公司 一种高纯度福司氟康唑制备方法
CN105985377A (zh) * 2015-02-09 2016-10-05 陕西合成药业股份有限公司 一种福司氟康唑盐水合物及其制备方法
CN106279280A (zh) * 2015-05-25 2017-01-04 西藏卫信康医药股份有限公司 一种化合物及其制备方法和应用
CN106518922A (zh) * 2015-09-12 2017-03-22 陕西合成药业股份有限公司 一种三唑类化合物及其制备方法和用途
CN106546668A (zh) * 2015-09-22 2017-03-29 陕西合成药业股份有限公司 一种分离福司氟康唑或其药用盐有关物质的hplc方法
CN105237569B (zh) * 2015-10-21 2017-07-25 西南科技大学 一种制备2，4‑二氟‑α，α‑二（1氢‑1，2，4‑三唑‑1‑基甲基）苯甲醇磷酸二苄酯的合成方法
CN105753902B (zh) * 2016-04-11 2017-08-25 浙江诚意药业股份有限公司 一种福司氟康唑的制备方法
CN108676031A (zh) * 2018-05-29 2018-10-19 重庆威鹏药业有限公司 水溶性三唑类抗真菌膦酸化合物及其制备方法和应用
CN111171075B (zh) * 2020-04-03 2022-07-12 北京四环生物制药有限公司 一种福司氟康唑的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
US4528284A (en) * 1982-10-15 1985-07-09 Ciba-Geigy Corporation Fungicidal 2-(azolylmethyl-1'-yl)-2-aryl-2-(cyano, alkoxycarbonyl, alkylthiocarbonyl and aminocarbonyl)-2-phosphorus acid esters
US4952232A (en) * 1987-04-29 1990-08-28 E. I. Du Pont De Nemours And Company Antifungal carbinols
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
US5278175A (en) * 1990-02-02 1994-01-11 Pfizer Inc. Triazole antifungal agents
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
TW211006B (da) * 1990-08-24 1993-08-11 Mochida Pharm Co Ltd
TW218017B (da) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
US5358939A (en) * 1992-06-25 1994-10-25 Rohm And Haas Company Fungicidal 2-aryl-2,2-disubstituted ethyl-1,2,4-triazoles
PL181947B1 (en) * 1994-01-24 2001-10-31 Janssen Pharmaceutica Nv Water-soluble azole-type antimycotic agents
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
EP0746318A1 (en) * 1994-02-25 1996-12-11 Takeda Chemical Industries, Ltd. Injectable emulsions containing antifungal triazole derivatives
GB9512961D0 (en) * 1995-06-26 1995-08-30 Pfizer Ltd Antifungal agents
FR2741061B1 (fr) * 1995-11-13 1998-03-20 Alcatel Fibres Optiques Procede de fabrication d'une fibre optique monomode et amplificateur optique utilisant une telle fibre
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
US5767977A (en) * 1996-12-19 1998-06-16 Hewlett-Packard Co. Method and apparatus for a carriage latch and power cord lock-out system for an optical scanner

Also Published As

Publication number Publication date
AP9700923A0 (en) 1997-01-31
PT880533E (pt) 2002-09-30
CZ291431B6 (cs) 2003-03-12
NO323771B1 (no) 2007-07-02
AU709781B2 (en) 1999-09-09
SA97170578B1 (ar) 2006-01-28
HRP970063A2 (en) 1998-06-30
IS4785A (is) 1998-06-26
EP0880533A1 (en) 1998-12-02
HN1997000012A (es) 1997-06-26
HUP9900949A2 (hu) 2001-05-28
WO1997028169A1 (en) 1997-08-07
PL328436A1 (en) 1999-02-01
KR100283546B1 (ko) 2001-04-02
ID15858A (id) 1997-08-14
UA46828C2 (uk) 2002-06-17
RS49526B (sr) 2006-12-15
DE69713284T2 (de) 2003-03-27
CZ242098A3 (cs) 1999-05-12
HRP970063B1 (en) 2001-12-31
US20030144250A1 (en) 2003-07-31
KR19990082233A (ko) 1999-11-25
HK1018217A1 (en) 1999-12-17
BR9707257A (pt) 1999-04-06
ATE219089T1 (de) 2002-06-15
PL187237B1 (pl) 2004-06-30
AP678A (en) 1998-09-28
IL124865A (en) 2002-03-10
CN1210540A (zh) 1999-03-10
IS1995B (is) 2005-03-15
NO983560D0 (no) 1998-08-03
CN1085213C (zh) 2002-05-22
IL133135A (en) 2003-07-06
CA2240777C (en) 2002-06-11
SK102298A3 (en) 1999-08-06
US6790957B2 (en) 2004-09-14
OA10711A (en) 2001-06-04
EP0880533B1 (en) 2002-06-12
US20040236105A1 (en) 2004-11-25
US20050130940A1 (en) 2005-06-16
CA2240777A1 (en) 1997-08-07
DE69713284D1 (de) 2002-07-18
ZA97826B (en) 1998-07-31
NZ330654A (en) 1999-08-30
MY116849A (en) 2004-04-30
SK283136B6 (sk) 2003-03-04
TR199801440T2 (xx) 1998-10-21
TNSN97023A1 (fr) 2005-03-15
TW434247B (en) 2001-05-16
GB9602080D0 (en) 1996-04-03
ES2175336T3 (es) 2002-11-16
US6977302B2 (en) 2005-12-20
JPH10512599A (ja) 1998-12-02
BG63946B1 (bg) 2003-07-31
BG102603A (en) 1999-03-31
GT199700016A (es) 1998-07-24
IL124865A0 (en) 1999-01-26
JP2959846B2 (ja) 1999-10-06
CO4761066A1 (es) 1999-04-27
HU226133B1 (en) 2008-05-28
NO983560L (no) 1998-08-03
AU1598597A (en) 1997-08-22
IL133135A0 (en) 2001-03-19
DZ2172A1 (fr) 2002-12-01
YU2997A (sh) 2000-10-30
HUP9900949A3 (en) 2001-08-28
SI0880533T1 (en) 2002-08-31
US20070027115A1 (en) 2007-02-01
RU2176244C2 (ru) 2001-11-27

Similar Documents

Publication Publication Date Title
DK0880533T3 (da) Triazolderivater, der er egnede i terapi
TR199501463A2 (tr) Triazolil türevleri.
ATE323682T1 (de) Aryl-pyrimidin-derivate
ATE261942T1 (de) 6-phenylpyridinderivate
EE9900211A (et) Asendatud pürasooliderivaadid
IS1902B (is) Nýjar 19-nor-pregnene afleiður
NO981946D0 (no) Imidazoquinazolin-derivater
NO975977D0 (no) Substituerte purinderivater, fremgangsmåter for fremstilling og anvendelse derav
DK0922050T3 (da) 3-Descladinose-2,3-anhydroerythromycin-derivater
DK1025100T3 (da) 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf
IS5026A (is) 2-metoxýfenýlpíperasín afleiður
ATE241599T1 (de) 25-hydroxy-16-ene-26,27-bishome-cholecalcerifer l derivate
ATE215547T1 (de) Kohlerhydratderivate
ATE193300T1 (de) 14alpha,17alpha-c2-überbrückte 19-nor- progesteronderivate
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
NO993024L (no) Polysakkarid-peptid-derivater
ES1029224Y (es) Tumbona perfeccionada.
ATA69896A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate
ATA73396A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate
SE9602645D0 (sv) Azabicyclic derivatives useful in therapy